4.6 Editorial Material

Erythrocyte-derived mitochondria: an unexpected interferon inducer in lupus

Journal

TRENDS IN IMMUNOLOGY
Volume 42, Issue 12, Pages 1054-1056

Publisher

CELL PRESS
DOI: 10.1016/j.it.2021.10.010

Keywords

-

Categories

Funding

  1. National Institutes of Health [R01 AI128901]

Ask authors/readers for more resources

Erythrocytes from lupus patients that fail to switch metabolic pathways retain their mitochondria, becoming a novel source of IFN when phagocytosed by macrophages.
Type 1 interferon (IFN) is a major contributor to the pathogenesis of systemic lupus erythematosus (SLE). A landmark study by Caielli et al. now shows that erythrocytes from lupus patients that fail to switch from glycolysis to oxidative phosphorylation during differenti-ation retain their mitochondria. These mitochondria-containing erythrocytes represent a novel source of IFN when phagocytosed by macrophages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available